Abstract
Dysregulation of microRNAs (miRNAs) has been linked to the progress of a number of autoimmune diseases including multiple sclerosis (MS), and its animal model, experimental autoimmune encephalomyelitis (EAE). IFN-γ-producing Th1 cells are major players in MS/EAE pathogenesis. It is known that differentiation of T cells towards the Th1 phenotype is influenced by various factors including miRNAs. The miR-92a shows substantial upregulation in MS; however, little is known about its role in the development of autoimmune and inflammatory responses. Herein, we investigated the role of miR-92a in the pathogenesis of MS, focusing on its potential effects on differentiation of Th1 cells. The expression levels of miR-92a were assessed in the spinal cord tissues and splenocytes from mice with EAE using real-time RT-PCR. Next, using transfection with miR-92a mimic sequences, the potential involvement of miR-92a in Th1 polarization was investigated by flow cytometric analysis. Moreover, the expression levels of miR-92a targets were explored in spinal cord tissues of EAE mice. miR-92a expression was enhanced in mouse spinal cord samples at the peak of EAE disease. Overexpression of miR-92a in splenocytes led to increased differentiation of Th1 cells compared with cells transfected with negative control sequences. Enhanced miR-92a expression was accompanied by reduced expression TSC1 or DUSP10, predicted miR-92a targets, in EAE spinal cords. Our data point to a potential role for miR-92a in neuroinflammatory responses in EAE. Our results indicate that miR-92a might affect Th1 differentiation, likely due to downregulation of TSC1 and DUSP10
Similar content being viewed by others
References
Compston, A., and A. Coles. 2008. Multiple sclerosis. Lancet 372 (9648): 1502–1517.
Mix, E., H. Meyer-Rienecker, H.P. Hartung, and U.K. Zettl. 2010. Animal models of multiple sclerosis—potentials and limitations. Progress in Neurobiology 92 (3): 386–404.
Amedei, A., D. Prisco, and M.M. D’Elios. 2012. Multiple sclerosis: The role of cytokines in pathogenesis and in therapies. International Journal of Molecular Sciences 13 (10): 13438–13460.
McFarland, H.F., and R. Martin. 2007. Multiple sclerosis: A complicated picture of autoimmunity. Nature Immunology 8 (9): 913–919.
Felekkis, K., E. Touvana, Ch. Stefanou, and C. Deltas. 2010. microRNAs: A newly described class of encoded molecules that play a role in health and disease. Hippokratia 14 (4): 236–240.
Wu, T., A. Wieland, K. Araki, C.W. Davis, L. Ye, J.S. Hale, and R. Ahmed. 2012. Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation. Proceedings of the National Academy of Sciences of the United States of America 109 (25): 9965–9970.
Thamilarasan, M., D. Koczan, M. Hecker, B. Paap, and U.K. Zettl. 2012. MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis. Autoimmunity Reviews 11 (3): 174–179.
Jin, X.F., Wu N, L. Wang, and J. Li. 2013. Circulating microRNAs: A novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cellular and Molecular Neurobiology 33 (5): 601–613.
Wu, W., H. Xiao, A. Laguna-Fernandez, G. Villarreal Jr., K.C. Wang, G.G. Geary, Y. Zhang, et al. 2011. Flow-dependent regulation of Kruppel-like factor 2 is mediated by MicroRNA-92a. Circulation 124 (5): 633–641.
Xiao, C., L. Srinivasan, D.P. Calado, H.C. Patterson, B. Zhang, J. Wang, J.M. Henderson, J.L. Kutok, and K. Rajewsky. 2008. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nature Immunology 9 (4): 405–414.
de Kouchkovsky, D., J.H. Esensten, W.L. Rosenthal, M.M. Morar, J.A. Bluestone, and L.T. Jeker. 2013. microRNA-17-92 regulates IL-10 production by regulatory T cells and control of experimental autoimmune encephalomyelitis. Journal of Immunology 191 (4): 1594–1605.
Noorbakhsh, F., K.K. Ellestad, F. Maingat, K.G. Warren, M.H. Han, L. Steinman, G.B. Baker, and C. Power. 2011. Impaired neurosteroid synthesis in multiple sclerosis. Brain 134 (Pt 9): 2703–2721.
Giuliani, F., L.M. Metz, T. Wilson, Y. Fan, A. Bar-Or, and V.W. Yong. 2005. Additive effect of the combination of glatiramer acetate and minocycline in a model of MS. Journal of Neuroimmunology 158 (1–2): 213–221.
Schellenberg, A.E., R. Buist, V.W. Yong, M.R. Del Bigio, and J. Peeling. 2007. Magnetic resonance imaging of blood-spinal cord barrier disruption in mice with experimental autoimmune encephalomyelitis. Magnetic Resonance in Medicine 58 (2): 298–305.
Miller, S.D., and W.J. Karpus. 2007. Experimental autoimmune encephalomyelitis in the mouse. In Current Protocols in Immunology
Talebi, F., S. Ghorbani, R. WF Chan, F. Boghozian, S. Masoumi, M. Ghasemi, C. Power Vojgani, and F. Noorbakhsh. 2017. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis. Journal of Neuroinflammation 14 (1): 55.
Ghorbani, S., F. Talebi, W.F. Chan, F. Masoumi, M. Vojgani, C. Power, and F. Noorbakhsh. 2017. MicroRNA-181 variants regulate T cell phenotype in the context of autoimmune Neuroinflammation. Frontiers in Immunology 8: 758.
Constantinescu, C.S., N. Farooqi, K. O’Brien, and B. Gran. 2011. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). British Journal of Pharmacology 164 (4): 1079–1106.
Chou, C.H., S. Shrestha, C.D. Yang, N.W. Chang, Y.L. Lin, K.W. Liao, W.C. Huang, et al. 2018. miRTarBase update 2018: A resource for experimentally validated microRNA-target interactions. Nucleic Acids Research 46 (D1): D296–D302.
He, G., L. Zhang, Q. Li, and L. Yang. 2014. miR-92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation. Biomedicine & Pharmacotherapy 68 (1): 25–30.
Park, Y., H.S. Jin, J. Lopez, C. Elly, G. Kim, M. Murai, M. Kronenberg, and Y.C. Liu. 2013. TSC1 regulates the balance between effector and regulatory T cells. Journal of Clinical Investigation 123 (12): 5165–5178.
Lang, R., M. Hammer, and J. Mages. 2006. DUSP meet immunology: Dual specificity MAPK phosphatases in control of the inflammatory response. Journal of Immunology 177 (11): 7497–7504.
Wu, T., A. Wieland, J. Lee, J.S. Hale, J.H. Han, Xu X, and R. Ahmed. 2015. Cutting edge: miR-17-92 is required for both CD4 Th1 and T follicular helper cell responses during viral infection. Journal of Immunology 195 (6): 2515–2519.
Jiang, S., C. Li, V. Olive, E. Lykken, F. Feng, J. Sevilla, Y. Wan, L. He, and Q.J. Li. 2011. Molecular dissection of the miR-17-92 cluster’s critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood 118 (20): 5487–5497.
Liu, S.Q., S. Jiang, C. Li, B. Zhang, and Q.J. Li. 2014. miR-17-92 cluster targets phosphatase and tensin homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation. Journal of Biological Chemistry 289 (18): 12446–12456.
Niu, H., K. Wang, A. Zhang, S. Yang, Z. Song, W. Wang, C. Qian, X. Li, Y. Zhu, and Y. Wang. 2012. miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11. Oncology Reports 28 (5): 1771–1777.
Ren, C., W. Wang, C. Han, H. Chen, Fu D, Y. Luo, H. Yao, et al. 2016. Expression and prognostic value of miR-92a in patients with gastric cancer. Tumor Biology 37 (7): 9483–9491.
Nilsson, S., C. Möller, K. Jirström, A. Lee, S. Busch, R. Lamb, and G. Landberg. 2012. Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration. PLoS One 7 (4): e36051.
Zhou, T., G. Zhang, Z. Liu, S. Xia, and H. Tian. 2013. Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. International Journal of Colorectal Disease 28 (1): 19–24.
Li, M., X. Guan, Y. Sun, J. Mi, X. Shu, F. Liu, and C. Li. 2014. miR-92a family and their target genes in tumorigenesis and metastasis. Experimental Cell Research 323 (1): 1–6.
Lv, X.B., X. Zhang, L. Deng, L. Jiang, W. Meng, Lu Z, and X. Wang. 2014. MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting Bim. Cell Biology International 38 (4): 435–443.
Ahmadi, S., M. Sharifi, and R. Salehi. 2016. Locked nucleic acid inhibits miR-92a-3p in human colorectal cancer, induces apoptosis and inhibits cell proliferation. Cancer Gene Therapy 23 (7): 199–205.
Carlsen, A.L., A.J. Schetter, C.T. Nielsen, C. Lood, S. Knudsen, A. Voss, C.C. Harris, et al. 2013. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis & Rheumatology 65 (5):1324–1334.
Kim, B.S., J.Y. Jung, J.Y. Jeon, H.A. Kim, and C.H. Suh. 2016. Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus. HLA 88 (4): 187–193.
Sing, T., M. Jinnin, K. Yamane, N. Honda, K. Makino, I. Kajihara, T. Makino, K. Sakai, S. Masuguchi, S. Fukushima, and H. Ihn. 2012. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma. Rheumatology (Oxford) 51 (9): 1550–1556.
Chen, Z., L. Wen, M. Martin, C.Y. Hsu, L. Fang, F.M. Lin, T.Y. Lin, et al. 2015. Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a. Circulation 131 (9): 805–814.
Loyer, X., S. Potteaux, A.C. Vion, C.L. Guérin, S. Boulkroun, P.E. Rautou, B. Ramkhelawon, et al. 2014. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circulation Research 114 (3): 434–443.
Manning, B.D., and L.C. Cantley. 2003. Rheb fills a GAP between TSC and TOR. Trends in Biochemical Sciences 28 (11): 573–576.
Delgoffe, G.M., K.N. Pollizzi, A.T. Waickman, E. Heikamp, D.J. Meyers, M.R. Horton, B. Xiao, P.F. Worley, and J.D. Powell. 2011. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nature Immunology 12 (4): 295–303.
Chornoguz, O., R.S. Hagan, A. Haile, M.L. Arwood, C.J. Gamper, A. Banerjee, and J.D. Powell. 2017. mTORC1 promotes T-bet phosphorylation to regulate Th1 differentiation. Journal of Immunology 198 (10): 3939–3948.
Nomura, M., K. Shiiba, C. Katagiri, I. Kasugai, K. Masuda, I. Sato, M. Sato, Y. Kakugawa, E. Nomura, K. Hayashi, Y. Nakamura, T. Nagata, T. Otsuka, R. Katakura, Y. Yamashita, M. Sato, N. Tanuma, and H. Shima. 2012. Novel function of MKP-5/DUSP10, a phosphatase of stress-activated kinases, on ERK-dependent gene expression, and upregulation of its gene expression in colon carcinomas. Oncology Reports 28 (3): 931–936.
Zhang, Y., J.N. Blattman, N.J. Kennedy, J. Duong, T. Nguyen, Y. Wang, R.J. Davis, P.D. Greenberg, R.A. Flavell, and C. Dong. 2004. Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5. Nature 430 (7001): 793–797.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
All experiments were performed in accordance with guidelines of the Research Ethics Committee of Isfahan University of Medical Sciences.
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All experiments were performed in accordance with guidelines of the Research Ethics Committee of Isfahan University of Medical Sciences (Code of Ethics: IR.MUI.REC.1394.3.134).
Rights and permissions
About this article
Cite this article
Rezaei, N., Talebi, F., Ghorbani, S. et al. MicroRNA-92a Drives Th1 Responses in the Experimental Autoimmune Encephalomyelitis. Inflammation 42, 235–245 (2019). https://doi.org/10.1007/s10753-018-0887-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-018-0887-3